비교리스트

 카트 문의
시장보고서
상품코드
1709451

세계의 유동성 지혈제 시장 : 제품 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Flowable Hemostats Market, By Product Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 322 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

유동성 지혈제 시장 규모는 2024년 7억 5,054만 달러로 평가되었고, 2025-2032년 연평균 복합 성장률(CAGR) 6.01%로 확대될 전망입니다.

지혈기술의 발전으로 지혈제의 효과가 더욱 빨라지고 생체적합성이 향상되고 있습니다. 또한, 최소 침습 수술에 대한 수요가 유동성 지혈제의 사용을 촉진하고 있습니다. 북미와 유럽은 선진화된 의료 시스템으로 시장을 선도하고 있으며, 아시아태평양은 빠른 성장세를 보이고 있습니다. 높은 비용과 규제적 장애물이 과제로 작용하고 있습니다. 그러나 의료에 대한 투자와 기술 혁신 증가는 시장 확대의 원동력이 되고 있습니다.

유동성 지혈제 시장 역학

세계 외과 수술 증가로 인한 지혈제 수요 증가

Lancet에 게재된 연구에 따르면, 전 세계적으로 매년 약 2억 3,400만 건의 대수술이 시행되는 것으로 추정되며, 이러한 수술 건수 증가는 유동성 지혈제 시장의 중요한 촉진요인입니다. 이러한 수술 건수는 수술 중 출혈을 관리할 수 있는 효과적인 지혈제의 중요한 필요성을 뒷받침합니다.

유동성 지혈제는 적용이 용이하고 출혈을 억제하는 효과가 높은 것으로 알려져 있으며, 외과 수술 도구 키트에서 필수적인 도구가 되고 있습니다. 세계 인구의 고령화와 만성 질환의 확산으로 외과적 개입에 대한 수요가 증가함에 따라 고급 지혈 솔루션에 대한 필요성이 더욱 높아질 것으로 예상됩니다.

유동성 지혈제 시장 : 주요 고려사항

당사의 리서치 애널리스트가 공유 한 분석에 따르면, 세계 시장은 예측 기간(2025-2032) 동안 약 6.01%의 연평균 복합 성장률(CAGR)로 연간 약 6.01%의 성장률을 보일 것으로 예측됩니다.

제품 유형별로는 젤라틴 기반 지혈제가 2024년 가장 큰 시장 점유율을 차지했습니다.

용도별로는 심혈관 수술이 2024년 주요 용도였습니다.

최종 사용자별로는 2024년 병원이 주요 최종 사용자로 나타났습니다.

지역별로는 북미가 2024년 매출을 주도했습니다.

유동성 지혈제 시장 : 세분화 분석

세계 유동성 지혈제 시장은 제품 유형, 용도, 최종 사용자 및 지역에 따라 세분화됩니다.

제품 유형에 따라 젤라틴 기반 지혈제, 콜라겐 기반 지혈제, 복합 지혈제, 트롬빈 기반 지혈제 등 4가지로 분류됩니다. 젤라틴 기반 지혈제는 다양한 수술 중 출혈을 조절할 수 있는 범용성, 유효성, 사용 편의성 등으로 인해 유동성 지혈제 시장을 독점하고 있습니다. 이 지혈제는 혈액을 빠르게 흡수하고 응고를 촉진하는 기계적 장벽을 형성하여 작동합니다. 심혈관 수술, 정형외과, 일반외과 등에서 널리 사용되며 시장을 주도하고 있습니다. 미국 식품의약국(FDA)에 따르면 젤라틴 기반 지혈제는 수술실에서 가장 일반적으로 승인되고 사용되는 지혈제 중 하나입니다. 생체 적합성, 적용 용이성, 불규칙한 상처 표면에 대한 효과로 인해 외과 의사들이 선호합니다. 또한, 최소 침습 수술 및 외상 사례 증가로 인해 수요가 더욱 증가하고 있습니다. 제형 개선, 흡수 속도 향상 등 끊임없는 발전을 통해 성능을 향상시켜 시장 리더로서의 입지를 확고히 하고 있습니다.

시장은 용도에 따라 심혈관외과, 정형외과, 일반외과, 신경외과, 부인과, 비뇨기과, 기타로 나뉩니다. 심혈관 수술은 효과적인 출혈 조절이 필요한 복잡한 수술이 많기 때문에 유동성 지혈제 시장을 독점하고 있습니다. 미국 질병예방통제센터(CDC)에 따르면 미국에서는 연간 약 80만 5,000건의 심장마비가 발생하고 있으며, 심장 수술의 급격한 증가를 주도하고 있습니다. 유동성 지혈제는 이러한 수술에서 섬세하고 접근하기 어려운 부위의 출혈을 관리하고 합병증 위험을 줄이기 위해 매우 중요합니다. 외과 의사들은 불규칙한 표면이나 출혈이 심한 부위에서도 지혈이 잘 되는 이 지혈제를 선호합니다. 심장 질환의 유병률 증가, 인구 고령화, 우회술 및 판막 치환술과 같은 심장 수술의 발전으로 인해 수요가 더욱 증가하고 있습니다. 저침습적 심혈관 치료로의 전환은 신속하고 효율적인 지혈 솔루션의 사용을 증가시켜 심혈관 수술을 주요 응용 분야로 확고히 하고 있습니다.

유동성 지혈제 시장 : 지역별 분석

북미는 많은 수술 건수와 선진화된 의료 인프라로 인해 유동성 지혈제 시장에서 큰 점유율을 차지하고 있습니다. 미국 질병통제예방센터(CDC)에 따르면, 미국에서는 연간 5,000만 건 이상의 수술이 이루어지고 있어 효과적인 지혈 솔루션에 대한 수요가 증가하고 있습니다. 이 지역에서는 FDA의 잦은 승인으로 인해 혁신적인 지혈제의 도입이 촉진되고 있습니다. 심혈관 질환 및 암과 같은 만성 질환의 확산으로 수술 건수가 증가하여 시장 성장을 더욱 촉진하고 있습니다. 또한, 외과적 개입에 취약한 노인 인구 증가는 고급 지혈제에 대한 수요에 기여하고 있습니다. 존슨앤드존슨, 박스터, 메드트로닉과 같은 주요 기업들은 제품의 효능을 높이기 위해 연구개발에 많은 투자를 하고 있습니다. 특히 외래수술센터(ASC)의 외래 수술 및 최소 침습 수술 증가도 수요를 촉진하고 있습니다. 전반적으로, 북미는 활발한 의료 지출과 기술 발전으로 인해 유동성 지혈제의 주요 시장으로 부상하고 있습니다.

CDC에 따르면, 미국에서는 연간 5,000만 건 이상의 수술이 이루어지고 있어 효과적인 지혈 솔루션에 대한 수요가 증가하고 있으며, 수술 건수와 첨단 의료 시설로 인해 미국은 유동성 지혈제 시장에서 큰 비중을 차지하고 있습니다. 존슨앤드존슨, 박스터, 메드트로닉과 같은 대기업의 존재는 지속적인 기술 혁신과 신제품 출시를 통해 시장 성장에 기여하고 있습니다. 또한, 고령화 인구 증가와 심혈관 질환 및 암과 같은 만성 질환의 유병률 증가는 외과적 개입을 촉진하고 있으며, FDA의 빈번한 승인을 통한 강력한 규제 프레임워크는 첨단 지혈 제품의 급속한 보급을 뒷받침하고 있습니다. 의료 연구에 대한 자금 지원 증가와 의료비 지출 증가도 시장 확대에 박차를 가하고 있습니다. 특히 외래수술센터(ASC)의 외래 환자 및 최소 침습 수술 증가는 사용하기 쉬운 지혈제에 대한 수요를 증가시키고 있습니다. 또한, 사고로 인한 외상도 응급 처치에서 유동성 지혈제 사용 증가에 기여하고 있습니다. 전반적으로 미국은 여전히 높은 성장 잠재력을 가진 주요 시장입니다.

유동성 지혈제 시장 : 경쟁 구도

유동성 지혈제 시장은 기술 발전, 제품 혁신, 주요 기업 간의 전략적 제휴로 인해 경쟁이 치열해지고 있습니다. 각 업체들은 유효성 향상, 빠른 적용, 우수한 생체적합성을 갖춘 지혈 솔루션을 도입하기 위해 연구개발에 집중하고 있으며, 미국 식품의약국(FDA)의 잦은 승인과 신제품 출시로 시장 확대에 박차를 가하고 있습니다. 병원 및 수술센터와의 합병, 인수, 제휴는 시장에서의 입지를 강화하기 위한 일반적인 전략입니다. 존슨앤드존슨(Ethicon), 박스터 인터내셔널(Floseal Hemostatic Matrix), 벡톤 딕킨슨 앤 컴퍼니(BD), 메드트로닉, 화이자와 같은 주요 기업들은 광범위한 지혈 솔루션으로 시장을 시장을 독점하고 있습니다. 또한 Stryker, Teleflex, CryoLife, CSL Behring, Hemostasis, LLC, Tissuemed Ltd와 같은 기업들은 지속적인 혁신을 통해 포트폴리오를 확장하고 있습니다. 경쟁 환경은 최소침습 수술 기술에 대한 투자와 의료 서비스 제공업체와의 제휴를 통해 더욱 치열하게 형성되고 있습니다. 이러한 치열한 경쟁은 제품의 성능, 안전성, 접근성을 향상시켜 시장의 지속적인 성장을 보장하고 있습니다.

목차

제1장 유동성 지혈제 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 유동성 지혈제 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 유동성 지혈제 시장 : 산업 분석

  • PEST 분석
  • Porter의 Five Forces 분석
  • 시장 성장 전망 : 맵핑
  • 규제 체제 분석

제5장 유동성 지혈제 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아-우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 유동성 지혈제 시장 구도

  • 유동성 지혈제 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 유동성 지혈제 시장 : 제품 유형별

  • 개요
    • 부문별 점유율 분석 : 제품 유형별
    • 젤라틴 기반 지혈제
    • 콜라겐 기반 지혈제
    • 복합 지혈 겸자
    • 트롬빈 기반 지혈제

제8장 유동성 지혈제 시장 : 용도별

  • 개요
    • 부문별 점유율 분석 : 용도별
    • 심장혈관 외과
    • 정형외과
    • 일반외과
    • 뇌신경외과
    • 부인과 수술
    • 비뇨기과 수술
    • 기타

제9장 유동성 지혈제 시장 : 최종사용자별

  • 개요
    • 부문별 점유율 분석 : 최종사용자별
    • 병원
    • 외래수술센터(ASC)
    • 전문 클리닉
    • 외상 센터

제10장 유동성 지혈제 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 유동성 지혈제 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Johnson &Johnson Services, Inc.
    • Baxter International Inc.
    • Becton, Dickinson and Company(BD)
    • Pfizer Inc.
    • Medtronic plc
    • Teleflex Incorporated
    • Integra LifeSciences Holdings Corporation
    • Stryker Corporation
    • CSL Behring LLC
    • CryoLife, Inc.
    • Ethicon, Inc.
    • Mallinckrodt Pharmaceuticals
    • Z-Medica, LLC
    • Hemostasis, LLC
    • Tissuemed Ltd
    • Biocer Entwicklungs-GmbH

제12장 AnalystView의 전방위적 분석

LSH 25.05.07

REPORT HIGHLIGHT

Flowable Hemostats Market size was valued at US$ 750.54 Million in 2024, expanding at a CAGR of 6.01% from 2025 to 2032.

The Flowable Hemostats Market focuses on products used to control bleeding during surgical procedures. Flowable hemostats are thick, gelatinous substances that combine a hemostatic agent with a carrier material, making them easy to apply to irregular wound surfaces. These hemostats work by accelerating the body's natural clotting process, helping to manage bleeding quickly and effectively. They are widely used in surgeries such as cardiovascular, orthopedic, and general procedures. The market is driven by the rising number of surgical procedures globally, an aging population, and increasing trauma cases.

Advancements in hemostatic technology, such as faster application and improved biocompatibility, are enhancing their effectiveness. Additionally, the demand for minimally invasive surgeries has boosted the use of flowable hemostats. North America and Europe currently lead the market due to advanced healthcare systems, while Asia-Pacific is experiencing rapid growth. Challenges include high costs and regulatory hurdles. However, increasing healthcare investments and innovations continue to drive market expansion.

Flowable Hemostats Market- Market Dynamics

Rising surgical procedures globally increasing demand for hemostatic solutions.

The increasing number of surgical procedures worldwide is a significant driver for the flowable hemostats market. A study published in The Lancet estimated that approximately 234 million major surgical procedures are performed globally each year. This high volume underscores the critical need for effective hemostatic agents to manage bleeding during surgeries.

Flowable hemostats, known for their ease of application and efficacy in controlling bleeding, are becoming essential tools in the surgical toolkit. As the global population ages and the prevalence of chronic diseases rises, the demand for surgical interventions is expected to increase, further propelling the need for advanced hemostatic solutions.

Flowable Hemostats Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2025-2032)

Based on product type segmentation, Gelatin-based hemostats was predicted to show maximum market share in the year 2024

Based on application segmentation, Cardiovascular surgery was the leading application in 2024

Based on End-user segmentation, Hospitals was the leading end-user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Flowable Hemostats Market- Segmentation Analysis:

The Global Flowable Hemostats Market is segmented on the basis of Product Type, Application, End-user, and Region.

The market is divided into Four categories based on product type: Gelatin-based Hemostats, Collagen-based Hemostats, Combination Hemostats, and Thrombin-based Hemostats. Gelatin-based hemostats dominate the flowable hemostats market due to their versatility, effectiveness, and ease of use in controlling bleeding during various surgical procedures. These hemostats work by absorbing blood rapidly and creating a mechanical barrier to promote clotting. Their widespread use in cardiovascular, orthopedic, and general surgeries drives their market leadership. According to the U.S. Food and Drug Administration (FDA), gelatin-based hemostats are among the most commonly approved and utilized hemostatic agents in operating rooms. Surgeons prefer them for their biocompatibility, ease of application, and effectiveness on irregular wound surfaces. Additionally, the rising number of minimally invasive surgeries and trauma cases has further fueled their demand. Continuous advancements, such as improved formulations and faster absorption rates, are enhancing their performance, solidifying their position as the market leader.

The market is divided into two categories based on application: Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Gynecological Surgery, Urology Surgery, Other. Cardiovascular surgery dominates the flowable hemostats market due to the high volume of complex procedures requiring effective bleeding control. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 heart attacks occur annually in the U.S., driving a surge in cardiac surgeries. Flowable hemostats are crucial in these surgeries to manage bleeding in delicate and hard-to-reach areas, reducing the risk of complications. Surgeons prefer them for their ability to work on irregular surfaces and in active bleeding sites. The increasing prevalence of heart diseases, aging populations, and advancements in cardiac procedures, such as bypass surgeries and valve replacements, further boost demand. The shift towards minimally invasive cardiovascular interventions has increased the use of quick and efficient hemostatic solutions, solidifying cardiovascular surgery as the leading application segment.

Flowable Hemostats Market- Geographical Insights

North America holds a major share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), over 50 million surgical procedures are performed annually in the U.S., increasing the demand for effective hemostatic solutions. The region benefits from frequent FDA approvals, which facilitate the introduction of innovative hemostatic products. The growing prevalence of chronic diseases, such as cardiovascular disorders and cancer, has increased the number of surgeries, further driving market growth. Additionally, a rising elderly population, which is more susceptible to surgical interventions, contributes to the demand for advanced hemostats. Major players like Johnson & Johnson, Baxter, and Medtronic are heavily investing in research and development to enhance product efficacy. The increase in outpatient procedures and minimally invasive surgeries, especially in ambulatory surgical centers, has also fueled demand. Overall, strong healthcare spending and technological advancements make North America a key market for flowable hemostats.

The United States holds a significant share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare facilities. According to the CDC, over 50 million surgeries are performed annually in the U.S., increasing the demand for effective bleeding control solutions. The presence of major players such as Johnson & Johnson, Baxter, and Medtronic contributes to market growth through continuous innovation and new product launches. Additionally, a growing aging population and rising prevalence of chronic diseases, such as cardiovascular disorders and cancer, are driving surgical interventions. The country's strong regulatory framework, with frequent FDA approvals, supports the rapid adoption of advanced hemostatic products. Increased funding for healthcare research and high healthcare expenditure further fuel market expansion. The rise in outpatient and minimally invasive surgeries, particularly in ambulatory surgical centers, has boosted demand for easy-to-use hemostats. Additionally, trauma cases from accidents contribute to increased usage of flowable hemostats in emergency procedures. Overall, the U.S. remains a key market with strong growth potential.

Flowable Hemostats Market- Competitive Landscape:

The flowable hemostats market is highly competitive, driven by technological advancements, product innovations, and strategic collaborations among key players. Companies are focusing on research and development to introduce hemostatic solutions with improved efficacy, faster application, and better biocompatibility. Frequent FDA approvals and new product launches are enhancing market expansion. Mergers, acquisitions, and partnerships with hospitals and surgical centers are common strategies to strengthen market presence. Leading players such as Johnson & Johnson (Ethicon), Baxter International (Floseal Hemostatic Matrix), Becton, Dickinson and Company (BD), Medtronic, and Pfizer dominate the market with a broad range of hemostatic solutions. Additionally, companies like Stryker, Teleflex, CryoLife, CSL Behring, Hemostasis, LLC, and Tissuemed Ltd are expanding their portfolios through continuous innovation. The competitive landscape is further shaped by investments in minimally invasive surgical technologies and collaborations with healthcare providers. This intense competition is driving improvements in product performance, safety, and accessibility, ensuring sustained market growth.

Recent Developments:

In April 2023, Baxter International Inc. unveiled multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023, including the launch of Floseal + Recothrom flowable hemostat. This helped the company to expand its product offerings and increase the reach of its product.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FLOWABLE HEMOSTATS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson Services, Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Pfizer Inc.
  • Medtronic plc
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • CSL Behring LLC
  • CryoLife, Inc.
  • Ethicon, Inc.
  • Mallinckrodt Pharmaceuticals
  • Z-Medica, LLC
  • Hemostasis, LLC
  • Tissuemed Ltd
  • Biocer Entwicklungs-GmbH

GLOBAL FLOWABLE HEMOSTATS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Gelatin-based Hemostats
  • Collagen-based Hemostats
  • Combination Hemostats
  • Thrombin-based Hemostats

GLOBAL FLOWABLE HEMOSTATS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Surgery
  • Orthopedic Surgery
  • General Surgery
  • Neurosurgery
  • Gynecological Surgery
  • Urology Surgery
  • Other

GLOBAL FLOWABLE HEMOSTATS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Trauma Centers

GLOBAL FLOWABLE HEMOSTATS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Flowable Hemostats Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Flowable Hemostats Market Snippet by Product Type
    • 2.1.2. Flowable Hemostats Market Snippet by Application
    • 2.1.3. Flowable Hemostats Market Snippet by End-user
    • 2.1.4. Flowable Hemostats Market Snippet by Country
    • 2.1.5. Flowable Hemostats Market Snippet by Region
  • 2.2. Competitive Insights

3. Flowable Hemostats Key Market Trends

  • 3.1. Flowable Hemostats Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Flowable Hemostats Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Flowable Hemostats Market Opportunities
  • 3.4. Flowable Hemostats Market Future Trends

4. Flowable Hemostats Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Flowable Hemostats Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Flowable Hemostats Market Landscape

  • 6.1. Flowable Hemostats Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Flowable Hemostats Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Gelatin-based Hemostats
    • 7.1.3. Collagen-based Hemostats
    • 7.1.4. Combination Hemostats
    • 7.1.5. Thrombin-based Hemostats

8. Flowable Hemostats Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Cardiovascular Surgery
    • 8.1.3. Orthopedic Surgery
    • 8.1.4. General Surgery
    • 8.1.5. Neurosurgery
    • 8.1.6. Gynecological Surgery
    • 8.1.7. Urology Surgery
    • 8.1.8. Other

9. Flowable Hemostats Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Specialty Clinics
    • 9.1.5. Trauma Centers

10. Flowable Hemostats Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Flowable Hemostats Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Flowable Hemostats Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Flowable Hemostats Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Flowable Hemostats Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Flowable Hemostats Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Flowable Hemostats Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.2. Baxter International Inc.
    • 11.2.3. Becton, Dickinson and Company (BD)
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Medtronic plc
    • 11.2.6. Teleflex Incorporated
    • 11.2.7. Integra LifeSciences Holdings Corporation
    • 11.2.8. Stryker Corporation
    • 11.2.9. CSL Behring LLC
    • 11.2.10. CryoLife, Inc.
    • 11.2.11. Ethicon, Inc.
    • 11.2.12. Mallinckrodt Pharmaceuticals
    • 11.2.13. Z-Medica, LLC
    • 11.2.14. Hemostasis, LLC
    • 11.2.15. Tissuemed Ltd
    • 11.2.16. Biocer Entwicklungs-GmbH

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제